These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 35441529

  • 1. Head-To-Head Comparison of 68Ga-PSMA-11 PET/CT and 99mTc-MDP Bone Scintigraphy for the Detection of Bone Metastases in Patients With Prostate Cancer: A Meta-Analysis.
    Zhao G, Ji B.
    AJR Am J Roentgenol; 2022 Sep; 219(3):386-395. PubMed ID: 35441529
    [Abstract] [Full Text] [Related]

  • 2. The diagnostic accuracy of 68Ga-PSMA PET/CT versus 99mTc-MDP bone scintigraphy for identifying bone metastases in persons with prostate cancer: A systematic review.
    Daniels H, Gilbert R, Bonin L.
    J Med Imaging Radiat Sci; 2023 Sep; 54(3):545-555. PubMed ID: 37211439
    [Abstract] [Full Text] [Related]

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.
    Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.
    Hell J Nucl Med; 2019 Sep; 22(1):6-9. PubMed ID: 30843003
    [Abstract] [Full Text] [Related]

  • 4. Prostate-specific membrane antigen PET versus [99mTc]Tc-MDP bone scan for diagnosing bone metastasis in prostate cancer: a head-to-head comparative meta-analysis.
    Wang Y, Qiu Y, Yan X.
    Front Med (Lausanne); 2024 Sep; 11():1451565. PubMed ID: 39386742
    [Abstract] [Full Text] [Related]

  • 5. Bone scintigraphy as a gatekeeper for the detection of bone metastases in patients with prostate cancer: comparison with Ga-68 PSMA PET/CT.
    Caglar M, Tuncel M, Yildiz E, Karabulut E.
    Ann Nucl Med; 2020 Dec; 34(12):932-941. PubMed ID: 32975741
    [Abstract] [Full Text] [Related]

  • 6. A prospective intra-individual comparison of [68Ga]Ga-PSMA-11 PET/CT, [68Ga]Ga-NODAGAZOL PET/CT, and [99mTc]Tc-MDP bone scintigraphy for radionuclide imaging of prostate cancer skeletal metastases.
    Lawal IO, Mokoala KMG, Mahapane J, Kleyhans J, Meckel M, Vorster M, Ebenhan T, Rösch F, Sathekge MM.
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):134-142. PubMed ID: 32424485
    [Abstract] [Full Text] [Related]

  • 7. 68Ga-PSMA PET/CT Replacing Bone Scan in the Initial Staging of Skeletal Metastasis in Prostate Cancer: A Fait Accompli?
    Lengana T, Lawal IO, Boshomane TG, Popoola GO, Mokoala KMG, Moshokoa E, Maes A, Mokgoro NP, Van de Wiele C, Vorster M, Sathekge MM.
    Clin Genitourin Cancer; 2018 Oct; 16(5):392-401. PubMed ID: 30120038
    [Abstract] [Full Text] [Related]

  • 8. Head-to-head comparison of 99mTc-PSMA and 99mTc-MDP SPECT/CT in diagnosing prostate cancer bone metastasis: a prospective, comparative imaging trial.
    Zhang Y, Lin Z, Li T, Wei Y, Yu M, Ye L, Cai Y, Yang S, Zhang Y, Shi Y, Chen W.
    Sci Rep; 2022 Sep 26; 12(1):15993. PubMed ID: 36163353
    [Abstract] [Full Text] [Related]

  • 9. Does bone scintigraphy still have a role in the era of 68 Ga-PSMA PET/CT in prostate cancer?
    Simsek DH, Sanli Y, Civan C, Engin MN, Isik EG, Ozkan ZG, Kuyumcu S.
    Ann Nucl Med; 2020 Jul 26; 34(7):476-485. PubMed ID: 32394269
    [Abstract] [Full Text] [Related]

  • 10. Comparison of Bone Uptake in Bone Scan and Ga-68 PSMA PET/CT Images in Patients with Prostate Cancer.
    Acar E, Bekiş R, Polack B.
    Curr Med Imaging Rev; 2019 Jul 26; 15(6):589-594. PubMed ID: 32008568
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL, Xue YL, Song HJ, Luo QY.
    Nucl Med Commun; 2012 Dec 26; 33(12):1232-42. PubMed ID: 23111353
    [Abstract] [Full Text] [Related]

  • 12. Comparison of hybrid 68Ga-PSMA-PET/CT and 99mTc-DPD-SPECT/CT for the detection of bone metastases in prostate cancer patients: Additional value of morphologic information from low dose CT.
    Janssen JC, Meißner S, Woythal N, Prasad V, Brenner W, Diederichs G, Hamm B, Makowski MR.
    Eur Radiol; 2018 Feb 26; 28(2):610-619. PubMed ID: 28779400
    [Abstract] [Full Text] [Related]

  • 13. 68Ga-PSMA PET/CT for the evaluation of metastasis in patients with prostate cancer: A systematic review and meta-analysis.
    Zhou J, Wu R, Wang W, Zhao Y, Liu X.
    Hell J Nucl Med; 2022 Feb 26; 25(3):297-311. PubMed ID: 36576728
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic Accuracy of 68Ga-PSMA PET/CT for Initial Detection in Patients With Suspected Prostate Cancer: A Systematic Review and Meta-Analysis.
    Satapathy S, Singh H, Kumar R, Mittal BR.
    AJR Am J Roentgenol; 2021 Mar 26; 216(3):599-607. PubMed ID: 32755196
    [Abstract] [Full Text] [Related]

  • 15. A Prospective Comparison of 18F-prostate-specific Membrane Antigen-1007 Positron Emission Tomography Computed Tomography, Whole-body 1.5 T Magnetic Resonance Imaging with Diffusion-weighted Imaging, and Single-photon Emission Computed Tomography/Computed Tomography with Traditional Imaging in Primary Distant Metastasis Staging of Prostate Cancer (PROSTAGE).
    Anttinen M, Ettala O, Malaspina S, Jambor I, Sandell M, Kajander S, Rinta-Kiikka I, Schildt J, Saukko E, Rautio P, Timonen KL, Matikainen T, Noponen T, Saunavaara J, Löyttyniemi E, Taimen P, Kemppainen J, Dean PB, Blanco Sequeiros R, Aronen HJ, Seppänen M, Boström PJ.
    Eur Urol Oncol; 2021 Aug 26; 4(4):635-644. PubMed ID: 32675047
    [Abstract] [Full Text] [Related]

  • 16. Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer.
    Pyka T, Okamoto S, Dahlbender M, Tauber R, Retz M, Heck M, Tamaki N, Schwaiger M, Maurer T, Eiber M.
    Eur J Nucl Med Mol Imaging; 2016 Nov 26; 43(12):2114-2121. PubMed ID: 27290607
    [Abstract] [Full Text] [Related]

  • 17. Comparison of Ga-68 PSMA positron emission tomography/computerized tomography with Tc-99m MDP bone scan in prostate cancer patients.
    Uslu-Beşli L, Sağer S, Akgün E, Asa S, Şahin OE, Demirdağ Ç, Güner E, Khosroshahi BR, Karayel E, Pehlivanoğlu H, Aygün A, Uslu İ, Talat Z, Sönmezoğlu K.
    Turk J Med Sci; 2019 Feb 11; 49(1):301-310. PubMed ID: 30761859
    [Abstract] [Full Text] [Related]

  • 18. How accurate is 68Gallium-prostate specific membrane antigen positron emission tomography / computed tomography (68Ga-PSMA PET/CT) on primary lymph node staging before radical prostatectomy in intermediate and high risk prostate cancer? A study of patient- and lymph node- based analyses.
    Erdem S, Simsek DH, Degirmenci E, Aydin R, Bagbudar S, Ozluk Y, Sanli Y, Sanli O, Ozcan F.
    Urol Oncol; 2022 Jan 11; 40(1):6.e1-6.e9. PubMed ID: 34400066
    [Abstract] [Full Text] [Related]

  • 19. Intra-individual comparison of 18F-sodium fluoride PET-CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial.
    Bénard F, Harsini S, Wilson D, Zukotynski K, Abikhzer G, Turcotte E, Cossette M, Metser U, Romsa J, Martin M, Mar C, Saad F, Soucy JP, Eigl BJ, Black P, Krauze A, Burrell S, Nichol A, Tardif JC.
    Lancet Oncol; 2022 Dec 11; 23(12):1499-1507. PubMed ID: 36343655
    [Abstract] [Full Text] [Related]

  • 20. A prospective, multicenter head-to-head comparative study in patients with primary high-risk prostate cancer investigating the bone lesion detection of conventional imaging and 18F-PSMA-PET/CT.
    Bodar YJL, Luining WI, Keizer B, Meijer D, Vellekoop A, Schaaf M, Hendrikse NH, Van Moorselaar RJA, Oprea-Lager DE, Vis AN.
    Urol Oncol; 2023 Apr 11; 41(4):205.e17-205.e24. PubMed ID: 36588019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.